Drug Trial News

RSS
Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Pfizer moves towards an oral anti-COVID-19 therapy

Pfizer moves towards an oral anti-COVID-19 therapy

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

New method predicts if COVID-19 clinical trials will be completed or suspended

New method predicts if COVID-19 clinical trials will be completed or suspended

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Potent nasal vaccine protects non-human primates from SARS-CoV-2

Potent nasal vaccine protects non-human primates from SARS-CoV-2

Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

Drug combination found to be safe and effective in malignant peritoneal mesothelioma patients

New OMV-based COVID-19 vaccine candidate proves effective in mice

New OMV-based COVID-19 vaccine candidate proves effective in mice

Dying patients with rare diseases struggle to get experimental therapies

Dying patients with rare diseases struggle to get experimental therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.